SHARE

Germany, Innovation, 2018

European Health Catapult Finalist SpinDiag showcased on German TV

15th August 2019

Fighting drug-resistant bacteria in hospitals

SpinDiag, one of the finalists in the European Health Catapult 2017, supported by EIT Health, was recently featured in a German TV news show. SpinDiag addresses the challenge of patients who introduce drug-resistant bacteria into hospitals with a new, rapid point-of-care screening system to test all risk patients for all relevant drug-resistances.

This affordable solution allows doctors to make an informed decision the spot about whether a patient needs to be isolated from others.

The team has now been portrayed on German Television SWR in a report that can be seen here, starting at minute 11:45 in this news show. SpinDiag, a German-based firm, is currently hiring a finance/office manager. See the current job offers here.

More information about SpinDiag can be found here

AI tool for COVID-19 produces significant results

AI tool for COVID-19 produces significant results

EIT Health project aids personalised medicine

Find out more

EIT Health helps Tubulis secure €10.7M in funding

EIT Health helps Tubulis secure €10.7M in funding

Investor Network aids firm doing antibody work

Find out more

EIT Health-backed start-ups garner big investments

EIT Health-backed start-ups garner big investments

A million each for iLoF and Restorative Neurotechnologies

Find out more